TRB Chemedica International

TRB Chemedica International Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von TRB Chemedica International, Route des Jeunes 33bis, Eaux-Vives.

For over 40 years, TRB Chemedica International have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology. TRB Chemedica is a Swiss pharmaceutical company, focus on research & development in specific therapeutic areas, including rheumatology, ophthalmology and neurology.

18/11/2025

The replay of our TRB Academy webinar held on June 30th, “Tailoring Injectable Treatments for Tendinopathies: From Evidence to Clinical Practice,” is now available. 👉Watch the replay https://bit.ly/4pdfxeG

Presented by Prof. Anja Hirschmüller, the session offer clear, evidence-based guidance on injectable treatements for tendinopathy management. If you missed the live session, you can now watch the full presentation and Q&A.

07/11/2025

Join us on Monday, December 1, from 6:00 PM to 7:00 PM (CET) for an expert-led TRB Academy session with Prof. Alkis Kalliakmanis.
Register now: https://bit.ly/3XhPHuc

📌 Topic: Optimizing Recovery After Arthroscopy: Tailored Pathways to Sport and Work Reintegration

Explore evidence-based strategies and personalized approaches to optimize post-arthroscopy recovery and support a safe, efficient return to sport and work.

Don’t miss this opportunity to learn more about rehabilitation approaches.

10/10/2025

This coming , how can we truly empower mobility, ease pain, and restore quality of life for millions worldwide?

At TRB Chemedica we believe the answer lies in progress, built on empathy and science — because everyone deserves the freedom to move without limits.
To everyone affected: You are not alone. Progress is possible. Together, we move forward. Learn more about our dedicated efforts in the field of arthritis treatment. https://bit.ly/4oeA3LQ

Save the date 📅 to connect with us at our booth to discuss our musculoskeletal and dry eye therapies, as well as opportu...
29/09/2025

Save the date 📅 to connect with us at our booth to discuss our musculoskeletal and dry eye therapies, as well as opportunities in in-licensing, out-licensing, and global distribution.
👉 Learn more about our expertise and CPHI Europe 2025
https://bit.ly/3Vk4mEc

We’re proud to exhibit at ISIAT 2025, where global experts in intra-articular therapy will explore the latest in viscosu...
11/09/2025

We’re proud to exhibit at ISIAT 2025, where global experts in intra-articular therapy will explore the latest in viscosupplementation, orthobiologics, and more. From consensus updates to joint preservation in athletes and ultrasound-guided injection workshops, this edition brings valuable insights for specialists in joint and musculoskeletal health.

💬 Meet the at Booth E in Bucharest and discover how our Swiss-engineered solutions are advancing joint care and mobility.

👉 Learn more about our MSK expertise and ISIAT 2025 events https://bit.ly/47ME0lD

04/09/2025

Osteoarthritis in small joints and TMJ can be a real challenge in clinical practice. Here’s a chance to deepen your expertise in just 45 minutes with a leading voice in the field.
📅 Date: Monday, September 29th
⏰ Time: 7:15 – 8:00 PM (CEST)
Join us for a focused clinical webinar on small joint and temporomandibular joint (TMJ) management, led by Stefano Stea, a consultant oral and maxillofacial surgeon in the UK. Register here https://one.wisembly.com/trbacademy

Mark your calendars and join us at ESCRS 2025 in Copenhagen, from 12–16 September!We will be exhibiting at Booth C4.018 ...
25/08/2025

Mark your calendars and join us at ESCRS 2025 in Copenhagen, from 12–16 September!
We will be exhibiting at Booth C4.018 and are excited to present our latest solutions in ocular surface health.

This year’s congress features exciting extras like the BoSS sustainability track and the 5K Charity Run through Amager Fælled, making it a must-attend event for ophthalmologists committed to innovation and impact. We look forward to connecting with you in Copenhagen!

Join TRB Chemedica at the EuDEC 2025 in Krakow, June 19-21! Visit us at Booth 9 to explore our trusted solutions and com...
05/06/2025

Join TRB Chemedica at the EuDEC 2025 in Krakow, June 19-21! Visit us at Booth 9 to explore our trusted solutions and commitment to improving patient care. We're also proud to welcome you on June 21 at 11:30am to our satellite symposium discussing a new European expert consensus on pediatric dry eye.



Find out more https://bit.ly/4jDhSwD

We’re proud to announce that an e-poster featuring TRB Chemedica’s Ostenil® Plus will be presented at the ISAKOS Congres...
28/05/2025

We’re proud to announce that an e-poster featuring TRB Chemedica’s Ostenil® Plus will be presented at the ISAKOS Congress 2025! The study compares the efficacy of our 2% sodium hyaluronate solution to corticosteroids in isolated patellofemoral osteoarthritis.

Presented by leading experts from Thailand, this research highlights the benefits of Ostenil® Plus in improving patient outcomes.

Visit us at Booth 21 to explore this study and our commitment to advancing musculoskeletal health.



Find out more https://buff.ly/YTZOqz3

Join us on June 30th from 6 PM to 7 PM (CET) for a TRB Academy webinar featuring Prof. Hirschmüller, renowned expert in ...
14/05/2025

Join us on June 30th from 6 PM to 7 PM (CET) for a TRB Academy webinar featuring Prof. Hirschmüller, renowned expert in sports medicine, orthopedics and traumatology.

📌Topic: Tailoring Injectable Treatments for Tendinopathies:
From Evidence to Clinical Practice

Discover the latest scientific insights and practical approaches for treating tendinopathies with injectable therapies.

🔗Register now
https://buff.ly/pO5XP8l

Be part of the conversation that connects cutting-edge research with hands-on clinical practice.

Join TRB Chemedica at the Isokinetic Conference in Madrid from May 3-5. Discover our commitment to enhancing musculoskel...
24/04/2025

Join TRB Chemedica at the Isokinetic Conference in Madrid from May 3-5. Discover our commitment to enhancing musculoskeletal health and improving patient outcomes. As a Swiss-based company, we pride ourselves on our dedication to quality and patient care. Visit us at Booth 29-31 to explore our solutions and engage with our and don't miss the chance to lift a replica of the Champions League cup on our booth! 🏆 😉
Find out more
https://bit.ly/4cO7eRQ

Join us at the 25th WCO-IOF-ESCEO Congress in Rome! From April 10-13, 2025, visit us at Stand n°2 to learn how TRB Cheme...
04/04/2025

Join us at the 25th WCO-IOF-ESCEO Congress in Rome! From April 10-13, 2025, visit us at Stand n°2 to learn how TRB Chemedica is advancing care for patients with musculoskeletal diseases. Osteoporosis and osteoarthritis are key focuses for us, and we’re eager to connect with you on this topic. Discover more about our expertise at https://bit.ly/44b2qU9

Adresse

Route Des Jeunes 33bis
Eaux-Vives
1227

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TRB Chemedica International erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an TRB Chemedica International senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Notre histoire

We are a market-leading pharma and biotechnology company, based in Switzerland and operating around the world.

Founded by Dr Guido Di Napoli in 1980, TRB Chemedica followed a gradual business evolution and expansion through the development of a worldwide network of subsidiaries and distributors.

For over 30 years, we have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology.

Our medium-sized company, supported by an exclusive network of affiliates, agents and partners, makes us efficient and responsive in the market, with the ability to develop customized solutions for patients and partners in our three focus areas that are hyluronic acid diacerein and GM1 ganglioside.